A Pilot Study: High Versus Low Oxytocin Dosing for Induction of Labor in Pregnant Patients With Obesity
Status:
Not yet recruiting
Trial end date:
2022-11-30
Target enrollment:
Participant gender:
Summary
Pregnant patients with obesity are more likely to undergo induction of labor and have a
higher risk of failed induction compared to patients with normal weight. The association
between maternal obesity and labor dysfunction leading to cesarean delivery is poorly
understood. Oxytocin is the mostly common medication used in induction of labor, yet optimal
dosing of this medication is unknown. Studies have suggested that patients with obesity may
be less responsive to oxytocin. This trial will compare a high and low dose oxytocin dosing
regimen for the induction of labor in women with obesity.